acute myeloid leukaemia (AML)

Capital

Nation

Politics

Issues

Global

Business

Sports

Health

More

Travel & Tourism

Science & Technology

Entertainment & Lifestyle

Gallery

acute myeloid leukaemia (AML)

Study finds immune therapy targets cells that cause leukemia relapse

Jun 3, 2022

Genetically engineered immune cells successfully targeted the specific cancer cells that may be responsible for relapse of acute myeloid leukaemia (AML)

Recent News

3 weeks ago

Madhav Nepal calls for working for national interests

3 weeks ago

Dr Bhattarai for forging common understanding on democratic consolidation and constitution protection

3 weeks ago

Quick bites of the day!

3 weeks ago

Rasuwagadhi Kerung International Highway to operate on Monday

3 weeks ago

CJ Raut for research, studies of judicial sector

Trending

Reception in honour of President Paudel in Berlin

Nepal defeated by Bangladesh

Landslide obstructs Muglin-Malekhu road section

Nepal's First Online News Portal

Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

Kathmandu, Nepal,

Newsroom
##

E-mail
[email protected]

Social Media

Facebook

Instagram

Twitter

Youtube

Exploration

About Us

Privacy Policy

Archive

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal